title: [Considerable improvement of spasticity and dystonic phenomena by sulfamethoxazole-trimethoprim in Joseph's disease].
authors.forename: H
authors.initials: H
authors.lastname: Dehen
authors.forename: S
authors.initials: S
authors.lastname: Sangla
authors.forename: T
authors.initials: T
authors.lastname: De Broucker
authors.forename: F
authors.initials: F
authors.lastname: Cheron
authors.forename: J
authors.initials: J
authors.lastname: Cambier
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004421:Dystonia / Q000188:drug therapy; D006801:Humans; D008297:Male; D009128:Muscle Spasticity / Q000188:drug therapy; D013132:Spinocerebellar Degenerations / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
chemical_list: D000890:Anti-Infective Agents; D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole
vernacular_title: Amélioration considérable de la spasticité et des phénomènes dystoniques par le sulfaméthoxazole-triméthoprime au cours d'une maladie de Joseph.